News
Omega Healthcare Investors has survived the storm, and now it is ready to ride the wave. Merck's dividend yield is a pleasing ...
These two reliable and high-yielding dividend payers from the healthcare sector should be on your buy list today.
A Newsweek report reveals America's Most Responsible Companies for 2025, with a New Jersey-based company earning the top spot ...
MRK scores an A+ grade for Profitability, aided by high gross and EBITDA margins of 78% and 46%, respectively. Moreover, it ...
Merck & Co., Inc. (NYSE: MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the ...
Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...
This podcast was recorded on July 21, 2025. Tim Beyers: Is it time to buy biotech? You're listening to Motley Fool Money.
3d
Zacks Investment Research on MSNInvestors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to KnowMerck (MRK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts ...
Merck & Co., Inc. (NYSE:MRK) is one of the top cheap pharmaceutical stocks to buy now. Goldman Sachs analyst Asad Haider ...
Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...
Merck has announced the acquisition of SpringWorks, which is expected to close this year, for an enterprise value of EUR 3 billion. While the deal appears expensive at an 18 times price/sales multiple ...
Merck & Co., Inc. (NYSE:MRK) is one of the Best Stocks to Invest in for High Returns. On July 30, Goldman Sachs analyst Asad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results